Pituitary Apoplexy

170 Pituitary Apoplexy





Epidemiology


Pituitary adenomas are common, with a prevalence of 3% to 27% in various autopsy series. They are rarely diagnosed in life, with a reported incidence of 4 per 100,000 in a Finnish population and a prevalence of 77 per 100,000 in a British one.1,2 Apoplexy occurs in a minority of such lesions and can occasionally be seen with normal glands. Because of the relative rarity of this condition, pituitary apoplexy may be confused with more common entities such as subarachnoid hemorrhage. Delay in diagnosis and treatment may lead to blindness, permanent cranial nerve palsies, or death.3,4



Pathophysiology


The two lobes of the pituitary gland sit within an enclosed space known as the sella turcica. Blood supply to this gland is one of the richest of all mammalian tissues.


The anterior lobe receives the portal hypophyseal vessel from the hypothalamus. Differentiated cells in the anterior lobe secrete specific hormones, including growth hormone (GH), adrenocorticotropic hormone (ACTH), prolactin (PRL), thyroid-stimulating hormone (TSH), and gonadotropins: luteinizing hormone (LH) and follicle-stimulating hormone (FSH).


The posterior lobe is an extension of the hypothalamus and secretes two hormones: antidiuretic hormone (or arginine vasopressin) and oxytocin. The pituitary stalk and the portal vessel pass through a small diaphragm that separates the sella turcica from the middle fossa. This anatomic arrangement places the pituitary at risk for infarction or hemorrhage when a mass increases pressure in the sella or compresses the stalk and vessels. Higher intrasellar pressures are associated with poor outcomes.


Pituitary tumors are common and many are asymptomatic. They are classified by size (microadenoma, <10 mm; macroadenoma, >10 mm) and by the hormone produced. Of tumors that cause clinical symptoms, the most commonly secreted hormones are PRL, which leads to hypogonadism; GH, which promotes acromegaly; and ACTH, a cause of Cushing disease.


Tumors involved in apoplexy are typically nonfunctional and unsuspected macroadenomas. In patients undergoing an endocrine stimulation test for hypogonadism, hypothyroidism, or adrenal insufficiency, apoplexy may occasionally develop secondary to stimulation of a macroadenoma. Treatment of a pituitary tumor can also precipitate apoplexy, particularly in cases of surgery, irradiation, or bromocriptine administration. Other reported risk factors include pregnancy (Sheehan syndrome), head trauma, recent cardiac surgery, anticoagulation, hypertension, diabetic ketoacidosis, and ovarian stimulation medications.5


Most patients with pituitary apoplexy have no identifiable risk factor. Apoplexy may occur in normal glands.



Presenting Signs and Symptoms



Classic


The findings in patients with pituitary apoplexy vary from mild headache to sudden collapse and coma. Most patients exhibit severe frontal or retroorbital headache, vomiting, impaired visual acuity, visual field defects, hypopituitarism, and subsequent adrenal crisis. A minority have ocular palsies, obtundation, meningismus, blindness, or long-tract signs. The visual field deficit is classically bitemporal upper quadrantopia or hemianopia. Associated cerebral infarction occasionally occurs secondary to vasospasm from subarachnoid hemorrhage or direct compression of the internal carotid artery by tumor. Table 170.1 lists the frequency of signs and symptoms reported in four case series.3,57


Table 170.1 Signs and Symptoms of Pituitary Apoplexy






























Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 14, 2016 | Posted by in EMERGENCY MEDICINE | Comments Off on Pituitary Apoplexy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access
SIGN OR SYMPTOM FREQUENCY (% INCIDENCE)
Headache 63-97
Visual field deficit 43-82
Hypopituitarism 81
Adrenal crisis 65
Vomiting 50
Visual impairment 60
Complete blindness 10
Ocular palsies 40-46